Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/192.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Fusion protein or fusion polypeptide (i.e., expression product of gene fusion)
Description: Subject matter involving a fusion protein or fusion polypeptide, which fusion protein or fusion polypeptide is taken to mean the expression product of a gene fusion.

Patents under this class:

Patent Number Title Of Patent Date Issued
8710009 HSP20 inhibits amyloidogenesis and neurotoxicity Apr. 29, 2014
8710004 Stable liquid VEGF antagonist formulations Apr. 29, 2014
8703702 Therapeutically active .alpha.-MSH analogues Apr. 22, 2014
8685939 Vaccine targeting cellular death receptor DR5 Apr. 1, 2014
8685407 Genetic constructs and compositions comprising RRE and CTE and uses thereof Apr. 1, 2014
8685406 Compositions of and method of using heat shock protein peptides Apr. 1, 2014
8679510 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia Mar. 25, 2014
8673870 Combined DNA vaccine and biological modifiers for cancer therapy Mar. 18, 2014
8669355 Vaccine Mar. 11, 2014
8663651 T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation Mar. 4, 2014
8658766 Soluble hybrid Fc.gamma. receptors and related methods Feb. 25, 2014
8658177 Promiscuous HER-2/Neu CD4 T cell epitopes Feb. 25, 2014
8652475 Inhibition of factor B, the alternative complement pathway and methods related thereto Feb. 18, 2014
8647634 Recombinant avian infectious coryza vaccine and process for preparing same Feb. 11, 2014
8647633 Recombinant F1-V plague vaccine Feb. 11, 2014
8647629 Powerful MHC-class II peptides derived from survivin Feb. 11, 2014
8642044 Prevention and treatment of amyloidogenic disease Feb. 4, 2014
8637053 Chlamydia antigens Jan. 28, 2014
8637044 Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and Jan. 28, 2014
8637042 Targeted particles and methods of using the same Jan. 28, 2014
8637039 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof Jan. 28, 2014
8632784 Nucleic acids and proteins from Streptococcus pneumoniae Jan. 21, 2014
8628779 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof Jan. 14, 2014
8628775 Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds Jan. 14, 2014
8623377 Joint-homing peptides and uses thereof Jan. 7, 2014
8623348 Interferon-.alpha. (IFN-.alpha.) fused proteins comprising IFN-.alpha. and a cytoplasmic transduction peptide (CTP) Jan. 7, 2014
8617566 Composition comprising VLP and amyloid beta peptide Dec. 31, 2013
8614183 Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2 Dec. 24, 2013
8603473 Modified binding molecules comprising connecting peptides Dec. 10, 2013
8597659 Tetrameric cytokines with improved biological activity Dec. 3, 2013
8597658 HIV-1 envelope glycoprotein oligomer and methods of use Dec. 3, 2013
8597656 Process for the production of immunogenic compositions Dec. 3, 2013
8592556 Phage .phi.mru polynucleotides and polypeptides and uses thereof Nov. 26, 2013
8591890 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality Nov. 26, 2013
8586709 Cell-permeabilising peptides and polypeptides for microbial cells Nov. 19, 2013
8586531 Erythropoietin immunoglobulin fusion proteins Nov. 19, 2013
8586052 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Nov. 19, 2013
8586048 G-CSF immunoglobulin fusion proteins Nov. 19, 2013
8586038 Chimeric immunoglobulin fusion proteins Nov. 19, 2013
8580936 Polynucleotides encoding FGFR1-IIIc ECD fusion proteins Nov. 12, 2013
8580743 Modified galectin 9 proteins and methods of treatment using them Nov. 12, 2013
8580273 TNF superfamily member light fusion proteins Nov. 12, 2013
8568989 Peptides and methods for the detection of Lyme disease antibodies Oct. 29, 2013
8568734 Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope Oct. 29, 2013
8568733 HER-2/neu fusion proteins Oct. 29, 2013
8563692 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities Oct. 22, 2013
8563508 Method for preventing or reducing acute renal failure by administration of therapeutically active .alpha.-MSH analogues Oct. 22, 2013
8563269 Modified antibody compositions, methods of making and using thereof Oct. 22, 2013
8563002 Recombinant RSV antigens Oct. 22, 2013
8557248 Methods and compositions for treating malaria Oct. 15, 2013

  Recently Added Patents
Method of making and using an alpha-glucanase composition to reduce or remove biofilm
Host route convergence based on sequence values
Tricyclic inhibitors of kinases
Methods and systems for time-shifting content
Pet bed
Multichannel device utilizing a centralized out-of-band authentication system (COBAS)
Quinoid thiophene organic photoelectric material, preparation method thereof and application thereof
  Randomly Featured Patents
PC card with variable width data bus communication capabilities
Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
Stabilized particulate composition
Dynamically channelizable packet transport network
Rotor shield for magnetic rotary machine
Contact measurement of container dimensional parameters
Breast prosthesis
High articulation dust boot for ball joint
System and method for integrating a message into a graphical environment
Method of providing pirfenidone therapy to a patient